x

Búsqueda de un ensayo clínico

* (*) Campo obligatorio

10 Resultado(s)

Ensayo clínico en reclutamiento = Ensayo clínico en reclutamiento
; Ensayos clínico en curso = Ensayos clínico en curso 
; Financiado por un miembro del IRDiRC = ; Miembro de una ERN =

Ensayo(s) clínico(s) nacional(es)

REINO UNIDO (EL)

Greater London
LONDON

CMT-TRAUK: Randomised double blind placebo controlled trial of long term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (Phase III) (Completed)
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

REINO UNIDO (EL)

Greater London
LONDON

PADIMAC: Phase II study of Bortezomib, Adriamycin and Dexamethasone (PAD) therapy for previously untreated patients with multiple myeloma: Impact of minimal residual disease (MRD) in patients with deferred ASCT - UK
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

REINO UNIDO (EL)

Greater London
LONDON

Bortezomib Consolidation Trial: A Phase II study of bortezomib consolidation after high dose therapy and autologous stem cell transplantation for multiple myeloma - UK
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

REINO UNIDO (EL)

Greater London
LONDON

Ensayos clínico en curso 
An Open-Label, Multicenter, Extension Study of AG-348 in Adult Subjects With Pyruvate Kinase Deficiency Previously Enrolled in AG-348 Studies-GB
Joint UCLH/UCL Biomedical Research and Development (R&D) Unit
University College London (UCL) and University College London Hospitals NHS Trust (UCLH)

REINO UNIDO (EL)

Greater London
LONDON

Ensayos clínico en curso 
Financiado por un miembro del IRDiRCPhase II Study of Arimoclomol for the Treatment of Sporadic Inclusion Body Myositis (IBM) - GB
UCL Institute of Neurology, University College London,
Clinical Neurosciences

REINO UNIDO (EL)

Greater London
LONDON

Ensayo clínico en reclutamiento
Ensayos clínico en curso 
COBALT: Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation
University College London Hospitals NHS Foundation Trust
Cancer Division